Prognostic Value of Ankle–Brachial Index in Patients Undergoing Percutaneous Coronary Intervention: In-Hospital and 1-Year Outcomes From the SHINANO Registry
Restricted accessResearch articleFirst published online November, 2017
Prognostic Value of Ankle–Brachial Index in Patients Undergoing Percutaneous Coronary Intervention: In-Hospital and 1-Year Outcomes From the SHINANO Registry
Concomitant coronary and peripheral artery disease is associated with higher periprocedural and long-term percutaneous coronary intervention (PCI) complication rates. We evaluated in-hospital and 1-year clinical outcomes of patients with low or borderline ankle–brachial indexes (ABIs) undergoing PCIs in the drug-eluting stent era. We divided 1370 SHINANO registry patients into 3 groups—low (ABI ≤ 0.9), borderline (0.9 < ABI ≤ 1.0), and normal (1.0 ≤ ABI < 1.4). During the 1-year follow-up, more PCI-related complications occurred in the low and borderline ABI groups than in the normal ABI group (7.7% vs 8.8% vs 4.0%, respectively). Low ABI patients were more likely to experience adverse clinical events (6.3% vs 3.6% vs 3.0%, respectively; log-rank P = .020 for low vs normal ABI), with a hazard ratio of 2.27 (95% confidence interval, 1.12-4.61; P = .023), compared with patients with normal ABIs. Patients with abnormal ABIs had a significantly higher incidence of PCI-related complications and a less favorable 1-year prognosis. Routine ABI measurement before PCI may help predict PCI-related complication incidence and 1-year prognosis.
StegPGBhattDLWilsonPW; REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherosclerosis. JAMA. 2007;297(11):1197–1206.
2.
DiehmCAllenbergJRPittrowD; German Epidemiological Trial on Ankle Brachial Index Study Group. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation. 2009;120(21):2053–2061.
3.
CarvounisCPNikasN. Prevalence of peripheral arterial disease in subjects at moderate cardiovascular risk: Greek results of the PANDORA study. Hellenic J Cardiol. 2014;55(4):294–304.
4.
CriquiMHAlbertsMJFowkesFGHirschATO’GaraPTOlinJW; American Heart Association Writing Group 2. Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted?Circulation. 2008;118(25):2830–2836.
5.
MenkeAMuntnerPWildmanRPDreisbachAWRaggiP. Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol. 2006;98(9):1226–1230.
6.
McDermottMMLiuKCriquiMH. Ankle brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2005;162(1):33–41.
7.
HealdCLFowkesFGMurrayGDPriceJF; Ankle Brachial Index Collaboration. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189(1):61–69.
8.
BertrandOFBélislePJoyalD. Comparison of transradial and femoral approaches for percutaneous coronary interventions: a systematic review and hierarchical Bayesian meta-analysis. Am Heart J. 2012;163(4):632–648.
9.
IkariYMatsukageTYoshimachiFMasutaniMSaitoS. Transradial and slender percutaneous coronary intervention: less invasive strategy in PCI. Cardiovasc Interv Ther. 2010;25(2):60–64.
10.
KirtaneAJGuptaAIyengarS. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation. 2009;119(25):3198–3206.
11.
MontalescotGBriegerDDalbyAJParkSJMehranR. Duration of dual antiplatelet therapy after coronary stenting: a review of the evidence. J Am Coll Cardiol. 2015;66(7):832–847.
12.
NessJAronowWS. Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J Am Geriatr Soc. 1999;47(10):1255–1256.
13.
BhattDLStegPGOhmanEM; REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180–189.
14.
SawJBhattDLMoliternoDJ. The influence of peripheral arterial disease on outcomes: a pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials. J Am Coll Cardiol. 2006;48(8):1567–1572.
15.
SinghMLennonRJDarbarDGershBJHolmesDRJrRihalCS. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intra coronary stents. Mayo Clin Proc. 2004;79(9):1113–1118.
16.
MiuraTMiyashitaYMotokiH. In-hospital clinical outcomes of elderly patients (≥ 80 years) undergoing percutaneous coronary intervention. Circ J. 2014;78(5):1097–1103.
17.
RookeTWHirschATMisraS. 2011ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(18):2020–2045.
18.
GreenlandPAbramsJAurigemmaGP. Prevention Conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101(1):e16–e22.
FowkesFGMurrayGDButcherI; Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197–208.
21.
OgrenMHedbladBIsacssonSOJanzonLJungquistGLindellSE. Non-invasively detected carotid stenosis and ischaemic heart disease in men with leg arteriosclerosis. Lancet. 1993;342(8880):1138–1141.
22.
LengGCFowkesFGLeeAJDunbarJHousleyERuckleyCV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996;313(7070):1440–1444.
23.
NewmanABShemanskiLManolioTA. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19(3):538–545.
24.
SebastianskiMNarasimhanSGrahamMM. Usefulness of the ankle-brachial index to predict high coronary SYNTAX scores, myocardium at risk, and incomplete coronary revascularization. Am J Cardiol. 2014;114(11):1745–1749.
25.
EndoAKawamuraAMiyataH; JCD-KICS Investigators. Angiographic lesion complexity score and in-hospital outcomes after percutaneous coronary intervention. PLoS One. 2015;10(6): e0127217.
26.
GrossmanPMGurmHSMcNamaraR; Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Percutaneous coronary intervention complications and guide catheter size: bigger is not better. JACC Cardiovasc Interv. 2009;2(7):636–644.
27.
HannaEBHennebryTA. Periprocedural myocardial infarction: review and classification. Clin Cardiol. 2010;33(8):476–483.
28.
MehranRDangasGMintzGS. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation. 2000;101(6):604–610.
29.
HerrmannJ. Peri-procedural myocardial injury: 2005 update. Eur Heart J. 2005;26(23):2493–2519.
30.
WernerNBauerTHochadelM. Incidence and clinical impact of stroke complicating percutaneous coronary intervention: results of the Euro Heart Survey Percutaneous Coronary Interventions Registry. Circ Cardiovasc Interv. 2013;6(4):362–369.
31.
KeeleyECGrinesCL. Scraping of aortic debris by coronary guiding catheters: a prospective evaluation of 1,000 cases. J Am Coll Cardiol. 1998;32(7):1861–1865.
32.
HamonMGomesSOppenheimC. Cerebral microembolism during cardiac catheterization and risk of acute brain injury: a prospective diffusion-weighted magnetic resonance imaging study. Stroke. 2006;37(8):2035–2038.
33.
AchterbergSVisserenFLKappelleLJPruissenDMVan Der GraafYAlgraA; Smart Study Group. Differential propensity for major hemorrhagic events in patients with different types of arterial disease. J Thromb Haemost. 2011;9(9):1724–1729.
34.
LeeSHChoiSHKimEK. Borderline ankle-brachial index is associated with poor short-term clinical outcome after coronary artery intervention. Atherosclerosis. 2016;249:186–190.
35.
DewildeWJOirbansTVerheugtFW. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381(9872):1107–1115.
36.
AnandSYusufSXieC; Warfarin Antiplatelet Vascular Evaluation Trial Investigators. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med. 2007;357(3):217–227.
37.
KaziDSLeongTKChangTISolomonMDHlatkyMAGoAS. Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention. J Am Coll Cardiol. 2015;65(14):1411–1120.
